2304 related articles for article (PubMed ID: 15588758)
1. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey.
García Santos JM; Gavrila D; Antúnez C; Tormo MJ; Salmerón D; Carles R; Jiménez Veiga J; Parrilla G; Torres del Río S; Fortuna L; Navarro C
Dement Geriatr Cogn Disord; 2008; 26(1):15-25. PubMed ID: 18566544
[TBL] [Abstract][Full Text] [Related]
3. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease.
Wang Z; Zhao C; Yu L; Zhou W; Li K
Acta Radiol; 2009 Apr; 50(3):312-9. PubMed ID: 19235582
[TBL] [Abstract][Full Text] [Related]
4. Conversion to dementia in mild cognitive impairment is associated with decline of N-actylaspartate and creatine as revealed by magnetic resonance spectroscopy.
Pilatus U; Lais C; Rochmont Adu M; Kratzsch T; Frölich L; Maurer K; Zanella FE; Lanfermann H; Pantel J
Psychiatry Res; 2009 Jul; 173(1):1-7. PubMed ID: 19427767
[TBL] [Abstract][Full Text] [Related]
5. Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease.
Ackl N; Ising M; Schreiber YA; Atiya M; Sonntag A; Auer DP
Neurosci Lett; 2005 Aug 12-19; 384(1-2):23-8. PubMed ID: 15905028
[TBL] [Abstract][Full Text] [Related]
6. A multicenter (1)H-MRS study of the medial temporal lobe in AD and MCI.
Jessen F; Gür O; Block W; Ende G; Frölich L; Hammen T; Wiltfang J; Kucinski T; Jahn H; Heun R; Maier W; Kölsch H; Kornhuber J; Träber F
Neurology; 2009 May; 72(20):1735-40. PubMed ID: 19451528
[TBL] [Abstract][Full Text] [Related]
7. Conversion of MCI to dementia: Role of proton magnetic resonance spectroscopy.
Metastasio A; Rinaldi P; Tarducci R; Mariani E; Feliziani FT; Cherubini A; Pelliccioli GP; Gobbi G; Senin U; Mecocci P
Neurobiol Aging; 2006 Jul; 27(7):926-32. PubMed ID: 15936850
[TBL] [Abstract][Full Text] [Related]
8. Proton spectroscopy in Alzheimer's disease and cognitive impairment no dementia: a community-based study.
Azevedo D; Tatsch M; Hototian SR; Bazzarella MC; Castro CC; Bottino CM
Dement Geriatr Cogn Disord; 2008; 25(6):491-500. PubMed ID: 18441524
[TBL] [Abstract][Full Text] [Related]
9. [Hydrogen proton MR spectroscopy of posterior portion cingulate gyrus of patients with Alzheimer's disease: a case control study].
Wang T; Xiao SF; Li X; Wang Y; Ding B; Ling HW; Chen KM
Zhonghua Yi Xue Za Zhi; 2009 Jan; 89(1):37-40. PubMed ID: 19489242
[TBL] [Abstract][Full Text] [Related]
10. Cortical brain metabolism as measured by proton spectroscopy is related to memory performance in patients with amnestic mild cognitive impairment and Alzheimer's disease.
Rami L; Gómez-Ansón B; Bosch B; Sánchez-Valle R; Monte GC; Villar A; Molinuevo JL
Dement Geriatr Cogn Disord; 2007; 24(4):274-9. PubMed ID: 17717413
[TBL] [Abstract][Full Text] [Related]
11. Absolute quantification in proton magnetic resonance spectroscopy is superior to relative ratio to discriminate Alzheimer's disease from Binswanger's disease.
Watanabe T; Shiino A; Akiguchi I
Dement Geriatr Cogn Disord; 2008; 26(1):89-100. PubMed ID: 18617735
[TBL] [Abstract][Full Text] [Related]
12. Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging.
Meyerhoff DJ; MacKay S; Constans JM; Norman D; Van Dyke C; Fein G; Weiner MW
Ann Neurol; 1994 Jul; 36(1):40-7. PubMed ID: 8024260
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of functional MRI markers in mild cognitive impairment.
Zhang B; Li M; Sun ZZ; Zhu B; Yuan L; Wang Y; Xu Y
J Clin Neurosci; 2009 May; 16(5):635-41. PubMed ID: 19264490
[TBL] [Abstract][Full Text] [Related]
14. White matter proton MR spectroscopy in children with isolated developmental delay: does it mean delayed myelination?
Fayed N; Morales H; Modrego PJ; Muñoz-Mingarro J
Acad Radiol; 2006 Feb; 13(2):229-35. PubMed ID: 16428059
[TBL] [Abstract][Full Text] [Related]
15. Diffusion tensor imaging correlates with proton magnetic resonance spectroscopy in posterior cingulate region of patients with Alzheimer's disease.
Ding B; Chen KM; Ling HW; Zhang H; Chai WM; Li X; Wang T
Dement Geriatr Cogn Disord; 2008; 25(3):218-25. PubMed ID: 18219201
[TBL] [Abstract][Full Text] [Related]
16. [1H-MR spectroscopic imaging in patients with clinically diagnosed Alzheimer's disease].
Block W; Träber F; Kuhl CK; Fric M; Keller E; Lamerichs R; Rink H; Möller HJ; Schild HH
Rofo; 1995 Sep; 163(3):230-7. PubMed ID: 7548870
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal metabolic and cognitive changes in mild cognitive impairment patients.
Olson BL; Holshouser BA; Britt W; Mueller C; Baqai W; Patra S; Petersen F; Kirsch WM
Alzheimer Dis Assoc Disord; 2008; 22(3):269-77. PubMed ID: 18580584
[TBL] [Abstract][Full Text] [Related]
18. Reproducibility of magnetic resonance spectroscopy in correlation with signal-to-noise ratio.
Okada T; Sakamoto S; Nakamoto Y; Kohara N; Senda M
Psychiatry Res; 2007 Nov; 156(2):169-74. PubMed ID: 17900878
[TBL] [Abstract][Full Text] [Related]
19. Single voxel proton magnetic resonance spectroscopy in women with and without intimate partner violence-related posttraumatic stress disorder.
Seedat S; Videen JS; Kennedy CM; Stein MB
Psychiatry Res; 2005 Aug; 139(3):249-58. PubMed ID: 16055312
[TBL] [Abstract][Full Text] [Related]
20. Utility of different MR modalities in mild cognitive impairment and its use as a predictor of conversion to probable dementia.
Fayed N; Dávila J; Oliveros A; Castillo J; Medrano JJ
Acad Radiol; 2008 Sep; 15(9):1089-98. PubMed ID: 18692749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
